innovative platform technology

Innovative Technology Platform

Entera's innovative technology enables oral drug delivery of large molecules

27163516 pills

Pipeline of Drug Development

Entera conducts clinical trials of three oral drugs based on a proven active compound

27163516 brain green

Experienced Management Team

The managers of Entera have more than 50 years of experience in drug development

August 20, 2014 - Entera's drug for hypoparathyroidism, enters Phase II clinical trials. The trials will include at least 15 hypoparathyroidism patients and will be carried out at the Lin Medical Center, Haifa as well as at the Hadassah Medical Center, Jerusalem.